Detalles de la búsqueda
1.
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.
Lancet Oncol
; 19(2): 216-228, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29339097
2.
A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients with solid tumors.
Invest New Drugs
; 32(5): 976-84, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24894650
3.
A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors.
Invest New Drugs
; 32(5): 937-45, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24916770
4.
Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.
Cancer Discov
; 6(10): 1106-1117, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27520294
5.
Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer.
Clin Cancer Res
; 18(11): 3163-9, 2012 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22496272
Resultados
1 -
5
de 5
1
Próxima >
>>